Pharmacokinetics and tissue distribution of tenofovir, emtricitabine and dolutegravir in mice

13Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Studies of antiretroviral drug (ARV) tissue distribution in preclinical models, such as mice, are key to understanding viral persistence. Objectives: To determine the plasma and tissue pharmacokinetics and tissue distributions of tenofovir, emtricitabine and dolutegravir in mice. Methods: ARVs were simultaneously administered to two different strains, and their levels in plasma and tissue samples were determined by a validated LC-MS/MS method. A non-compartmental analysis was performed to estimate the main pharmacokinetic parameters. A tissue penetration factor (TPF) was calculated as the ratio of the concentration in the tissue concerned to that in plasma. Results: ARV plasma pharmacokinetic parameters in both strains were similar to those estimated in the clinical context. Tissue concentrations were highest in the digestive tract, followed by the liver and kidneys, lymphatic system, pancreas, adipose tissue and lungs. Tissue concentrations were lowest in the brain. Triple therapy could not be considered effective in any of the tissues considered. The TPF values obtained showed that tenofovir diffused widely, especially in the digestive tract, liver and kidneys. Emtricitabine had a TPF above 100% in two-thirds of the tissues. Dolutegravir was poorly distributed to all tissues. Conclusions: Drug specificity was observed, with higher levels of exposure to tenofovir than to emtricitabine or dolutegravir. Tissue specificity was also observed, with strong penetration of the digestive tract and weak penetration of the brain. These data have important implications for future preclinical and clinical studies for developing new HIV therapies with the goal of an HIV cure.

References Powered by Scopus

Humanized mice for immune system investigation: Progress, promise and challenges

776Citations
N/AReaders
Get full text

Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain

775Citations
N/AReaders
Get full text

Cyclodextrins in drug delivery

679Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Differential Protective Effect of Resveratrol and Its Microbial Metabolites on Intestinal Barrier Dysfunction is Mediated by the AMPK Pathway

26Citations
N/AReaders
Get full text

Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND)

13Citations
N/AReaders
Get full text

HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Labarthe, L., Gelé, T., Gouget, H., Benzemrane, M. S., Le Calvez, P., Legrand, N., … Barrail-Tran, A. (2022). Pharmacokinetics and tissue distribution of tenofovir, emtricitabine and dolutegravir in mice. Journal of Antimicrobial Chemotherapy, 77(4), 1094–1101. https://doi.org/10.1093/jac/dkab501

Readers over time

‘22‘23‘240481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

80%

Professor / Associate Prof. 1

10%

Lecturer / Post doc 1

10%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 6

55%

Medicine and Dentistry 2

18%

Immunology and Microbiology 2

18%

Veterinary Science and Veterinary Medic... 1

9%

Save time finding and organizing research with Mendeley

Sign up for free
0